A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants

Clinical trial NCT06970301 · COMPLETED

Trial details

NCT number: NCT06970301
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Study Participants

Start date: 2025-04-28
Primary completion: 2026-05-29
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.